Estimates of GFR were calculated on the basis of serum creatinine, cystatin C and creatinine-cystatin C, according to the equations of the Chronic Kidney Disease Epidemiology Collaboration16 (link),17 (link). Venous blood was drawn from all study participants at the examination appointment and sent to the laboratory department of Augsburg Central Hospital within 2 to 4 h. Serum creatinine concentration were analyzed using an enzymatic colorimetric method (Dimension Vista 1500, Siemens Healthcare Diagnostics, Eschborn, Germany, or Cobas c702, Roche Diagnostics GmbH, Mannheim, Germany). Cystatin C levels were assessed using a nephelometric immunoassay (normal range 0.50–0.96 mg/L, Roche Diagnostics GmbH, Mannheim, Germany)18 (link),19 (link). Urinary albumin concentration was measured using an immunoturbidimetric assay (Tina-quant_Albumin in Urine, Boehringer Mannheim, Germany) from a single urine sample stored at − 80 °C19 (link). eGFR was calculated on the basis of the Chronic Kidney Disease Epidemiology Collaboration equation, which is based on both serum creatinine and cystatin C16 (link).
Free full text: Click here